Related Experiment Videos
[Membranous glomerulonephritis in children: 20 cases].
S Locard-Bisot1, P Cochat, J Gilly
1Unité de néphrologie pédiatrique, hôpital Edouard-Herriot, Lyon, France.
Summary
This study on pediatric membranous glomerulonephritis found that while many children recover from proteinuria, some develop persistent symptoms or end-stage renal failure. Idiopathic cases are most common, highlighting the need for ongoing research into this kidney disease.
Area of Science:
- Nephrology
- Pediatric Nephrology
- Immunopathology
Context:
- Membranous glomerulonephritis (MGN) is a significant cause of nephrotic syndrome in children.
- Understanding the long-term outcomes and etiological factors in pediatric MGN is crucial for effective management.
- This study reviews a cohort of pediatric MGN cases diagnosed over a decade.
Purpose:
- To analyze the clinical presentation, histological findings, etiology, and long-term outcomes of membranous glomerulonephritis in children.
- To identify potential risk factors and prognostic indicators for disease progression in pediatric MGN.
- To evaluate the impact of D-penicillamine and HBs antigen on the development of MGN.
Summary:
- Twenty pediatric cases of MGN were analyzed, with a median follow-up of 5.1 years.
- Proteinuria and microscopic hematuria were common, with some cases progressing to nephrotic syndrome or renal failure.
- Histopathology revealed stage II MGN with significant immunoglobulin and C3 deposits. Idiopathic cases predominated (85%), with D-penicillamine and HBs antigen identified in a minority.
- While 38% of patients achieved complete remission of proteinuria, 55% had persistent proteinuria. One case progressed to end-stage renal failure.
Impact:
- Provides valuable insights into the natural history and prognosis of pediatric membranous glomerulonephritis.
- Highlights the heterogeneity of disease presentation and outcome in children with MGN.
- Informs clinical decision-making and underscores the need for further research into the pathogenesis and treatment of pediatric MGN.